Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Morimoto

Showing results (281-290 of 313) with videos related to

Pageof 32
Sort By:
Oral Diseases|October 9, 2016
PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivoJ Teramachi, Y Inagaki, H Shinohara, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapyH Nagaoka, T Monden, I Sakita, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2AA Miya, M Yamamoto, H Morimoto, et al.
Lancet (London, England)|October 21, 1995
Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisS Nishiguchi, T Kuroki, S Nakatani, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1988
Studies on peptides. CLX. Synthesis of a 33-residue peptide corresponding to the entire amino acid sequence of human cholecystokinin (hCCK-33)N Fujii, S Futaka, S Funakoshi, et al.
Journal of Biomolecular NMR|May 1, 1996
Applications of tritium NMR to macromolecules: a study of two nucleic acid moleculesM G Kubinec, A S Culf, H Cho, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude miceY Nio, T Shiraishi, M Tsubono, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Journal of Medicinal Chemistry|October 5, 2001
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivativesH Morimoto, H Shimadzu, E Kushiyama, et al.
Journal of Molecular Biology|April 20, 1991
Site-directed mutagenesis in haemoglobin. Functional role of tyrosine-42(C7) alpha at the alpha 1-beta 2 interfaceK Imai, K Fushitani, G Miyazaki, et al.
Pageof 32

Showing results (281-290 of 313) with videos related to

Sort By:
Pageof 32
Oral Diseases|October 9, 2016
PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivoJ Teramachi, Y Inagaki, H Shinohara, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapyH Nagaoka, T Monden, I Sakita, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2AA Miya, M Yamamoto, H Morimoto, et al.
Lancet (London, England)|October 21, 1995
Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisS Nishiguchi, T Kuroki, S Nakatani, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1988
Studies on peptides. CLX. Synthesis of a 33-residue peptide corresponding to the entire amino acid sequence of human cholecystokinin (hCCK-33)N Fujii, S Futaka, S Funakoshi, et al.
Journal of Biomolecular NMR|May 1, 1996
Applications of tritium NMR to macromolecules: a study of two nucleic acid moleculesM G Kubinec, A S Culf, H Cho, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude miceY Nio, T Shiraishi, M Tsubono, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Journal of Medicinal Chemistry|October 5, 2001
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivativesH Morimoto, H Shimadzu, E Kushiyama, et al.
Journal of Molecular Biology|April 20, 1991
Site-directed mutagenesis in haemoglobin. Functional role of tyrosine-42(C7) alpha at the alpha 1-beta 2 interfaceK Imai, K Fushitani, G Miyazaki, et al.
Pageof 32